Loading...
NPI 1598766495 · Lafayette, LA · General Acute Care Hospital
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Our Lady Of Lourdes Regional Medical Center, Inc is a general acute care hospital provider located in Lafayette, Louisiana. This profile covers 0 Medicare and 257 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Our Lady Of Lourdes Regional Medical Center, Inc |
| Address | 4801 Ambassador Caffery Pkwy |
| City | Lafayette |
| State | LA |
| ZIP | 70508 |
| Taxonomy | General Acute Care Hospital |
| NPI Enumerated | August 2, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $54.3M |
| Medicare | $0 |
This provider reports no Medicare billing on file and $54.3M in lifetime Medicaid revenue, so its public claims footprint is effectively single‑payer and concentrated in Medicaid. Analysts should treat Medicaid as the primary commercial touchpoint for assessing volume, utilization, and contracting leverage for this facility.
The code mix signals a high-volume emergency department and acute care operation rather than primarily outpatient clinic activity. The dominance of ED E/M codes (99284, 99283, and a supporting volume of 99285 and 99282) plus G0378 observation hours ($863.1K, 1.8%) and 99291 critical care ($746.5K, 1.6%) indicates the hospital manages substantial unscheduled and higher‑acuity ED throughput.
Laboratory and proprietary testing are meaningful secondary revenue drivers: 0241U is a top line item at $3.2M (6.9%) and ranks #1 of 95 in-state (100th percentile), and PLA/respiratory testing 0202U produced $2.8M (6.0%) and ranks #4 of 60 (95th percentile). High volumes in infectious-disease tests (87635 $946.3K, 97th percentile; 87651 $859K, 99th percentile; 87804 $525.4K, 98th percentile) reinforce that lab diagnostics tied to acute respiratory and infectious presentations are a consistent service line.
On competitive standing within Louisiana the hospital is a major ED player: 99283 ranks #4 of 266 providers in-state (99th percentile, labeled an extreme outlier) and 99284 ranks #18 of 266 (94th percentile, notably above typical state volume). The facility’s #1 rank for 0241U (100th percentile) further underscores dominance in certain lab/PLA categories statewide.
Beyond the ED and lab profile, the hospital offers a breadth of diagnostic and specialty services that generate nontrivial Medicaid revenue. Imaging and advanced diagnostics appear in the mix (70450 CT head $891.6K, 1.9%; 74177 CT abdomen/pelvis $621.1K, 1.3%) and sleep medicine services are present (95810 $773.3K, 1.6% and 95811 $474.1K, 1.0%, both at higher state percentiles), indicating integrated inpatient/outpatient capabilities.
Therapeutic and medication‑administration activity is also prominent: rapid IV push and sequential infusions (96374 $1.4M, 3.0%; 96375 $766.9K, 1.6%) and injection services (96372 $522.3K, 1.1%) are high-volume relative to peers (multiple codes rank in the top deciles statewide). This pattern is consistent with active ED treatment, observation care and in‑hospital procedural therapy rather than a purely diagnostic facility.
The provider’s NPI was enumerated on 2005-08-02 (~21 years ago), indicating long tenure as an established regional hospital. Combined with concentrated Medicaid revenue and outsized state ranks for several high‑volume codes, the facility represents a durable Medicaid network asset with concentrated ED and diagnostic capabilities that payers and competitors should flag during contracting and network planning.
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
257 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 74,690 | $150 | $11.4M |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 131,730 | $80 | $10.9M |
| 0241U | N/A | 35,560 | $90 | $3.2M |
| 99285 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a high level of medical decision making. | 21,440 | $130 | $2.9M |
| 0202U | This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0202U for the… | 9,600 | $300 | $2.8M |
| 16020 | This CPT code is for the dressing and/or debridement of a partial–thickness burn (either initially or subsequently). In this instance the burn is small (less than 5% of the total body surface area). | 6,070 | $250 | $1.5M |
| 96374 | The provider administers a single medication or other substance rapidly into a vein to treat, prevent, or diagnose a condition. | 41,920 | $30 | $1.4M |
| 99282 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a straightforward level of medical decision making. | 20,630 | $50 | $1.1M |
| 93005 | The provider records the electrical conduction of the heart to examine any abnormality in its functioning, based on signals from at least 12 leads, wires that connect the recording device to… | 27,770 | $40 | $1M |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 26,290 | $40 | $946.3K |
Showing 1–10 of 257
How this provider's Medicaid billing volume and revenue compare to other Louisiana providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Louisiana median
257 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 18 | 270 | 9,980 | $110 | $2.6M |
| 99285 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a high level of medical decision making. | 62 | 240 | 4,030 | $130 | $2M |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 4 | 270 | 11,250 | $90 | $1.8M |
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 17 | 70 | 620 | $230 | $913.4K |
| 0202U | This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0202U for the… | 4 | 60 | 1,160 | $280 | $690.6K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 70 | 100 | 620 | $40 | $560K |
| 74177 | The provider performs computed tomography of the abdomen and pelvis with contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs. | 28 | 100 | 760 | $100 | $441.2K |
| 41899 | Use this code to report a procedure on the teeth and adjoining alveolar structures for which there is no specific code available. | 21 | 30 | 160 | $520 | $413.4K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 34 | 90 | 650 | $40 | $404.2K |
| 16020 | This CPT code is for the dressing and/or debridement of a partial–thickness burn (either initially or subsequently). In this instance the burn is small (less than 5% of the total body surface area). | 1 | 10 | 80 | $230 | $360.6K |
Showing 1–10 of 257
Other providers in the same ZIP code as Our Lady Of Lourdes Regional Medical Center, Inc, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Acadian Ambulance Service, Inc. | LA | Air Ambulance | $38.7M | $422.7M |
| Pediatric Group Of Acadiana, LLC | LA | Specialist | $0 | $57.5M |
| Leading Health Care Of La | LA | In Home Supportive Care Agency | $0 | $57.4M |
| Sleep Management, L.L.C. | LA | Oxygen Equipment & Supplies (DME) | $0 | $41.8M |
| Medi Trans, LLC | LA | Transportation Broker | $0 | $29.8M |
| L & D Community Care, Inc | LA | In Home Supportive Care Agency | $0 | $24.4M |
| Acadiana Acute Care Associates, LLC | LA | Emergency Medicine Physician | $0 | $20.4M |
| Lourdes After Hours LLC | LA | Urgent Care Clinic/Center | $0 | $20.2M |
| Laboratory Corporation Of America | LA | Clinical Medical Laboratory | $1.9M | $12.4M |
| Leading Health Care Of La | LA | In Home Supportive Care Agency | $0 | $12.8M |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.